Eosinophils in the Tumor Microenvironment.

Angiogenesis CD8+ T cells Cancer Cationic proteins Cytotoxicity Eosinophil Exosomes Extracellular Traps Immune regulation Lymphangiogenesis Mast cell Mouse models Tumor Immunity Tumor Microenvironment Tumor prognostic value

Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2020
Historique:
entrez: 29 10 2020
pubmed: 30 10 2020
medline: 14 1 2021
Statut: ppublish

Résumé

Eosinophils are rare blood-circulating and tissue-infiltrating immune cells studied for decades in the context of allergic diseases and parasitic infections. Eosinophils can secrete a wide array of soluble mediators and effector molecules, with potential immunoregulatory activities in the tumor microenvironment (TME). These findings imply that these cells may play a role in cancer immunity. Despite these cells were known to infiltrate tumors since many years ago, their role in TME is gaining attention only recently. In this chapter, we will review the main biological functions of eosinophils that can be relevant within the TME. We will discuss how these cells may undergo phenotypic changes acquiring pro- or antitumoricidal properties according to the surrounding stimuli. Moreover, we will analyze canonical (i.e., degranulation) and unconventional mechanisms (i.e., DNA traps, exosome secretion) employed by eosinophils in inflammatory contexts, which can be relevant for tumor immune responses. Finally, we will review the available preclinical models that could be employed for the study of the role in vivo of eosinophils in cancer.

Identifiants

pubmed: 33119873
doi: 10.1007/978-3-030-49270-0_1
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-28

Auteurs

Fabrizio Mattei (F)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

Sara Andreone (S)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

Giancarlo Marone (G)

Department of Public Health, University of Naples Federico II, Naples, Italy.
Azienda Ospedaliera Ospedali dei Colli - Monaldi Hospital Pharmacy, Naples, Italy.

Adriana Rosa Gambardella (AR)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

Stefania Loffredo (S)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
WAO Center of Excellence, Naples, Italy.
Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy.

Gilda Varricchi (G)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy. gildanet@gmail.com.
WAO Center of Excellence, Naples, Italy. gildanet@gmail.com.
Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy. gildanet@gmail.com.

Giovanna Schiavoni (G)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. giovanna.schiavoni@iss.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH